Alzheimer’s disease remains one of the most significant challenges to modern medicine, currently affecting an estimated 7.2 million Americans age…
Read More
Unlocking the Mechanism of Lecanemab: VIB-KU Leuven Researchers Identify Fc Fragment as Essential for Microglial Activation in Alzheimer’s Treatment
Researchers from the VIB-KU Leuven Center for Brain & Disease Research have published a seminal study in the journal Nature…
Read More
Revolutionary Blood Test Model Forecasts Alzheimer’s Symptom Onset, Reshaping Early Detection and Clinical Trial Strategies
Clinical laboratories across the globe are keenly observing a pivotal shift in neurodegenerative disease diagnostics, particularly with the escalating prominence…
Read More
Microplastics and Neurodegeneration: New Research Links Synthetic Particles to Alzheimer’s and Parkinson’s Disease Risks
The global escalation of plastic pollution has long been recognized as a primary threat to marine ecosystems and environmental stability,…
Read MoreYOU MAY HAVE MISSED
